New research suggests the protection the Moderna vaccine gives against COVID-19 lasts for at least six months.
The report Tuesday in the New England Journal of Medicine echoes what Pfizer said last week about its vaccine, which works in a similar way.
Both reports were based on follow-up tests in dozens of people who received the shots during studies that led to the vaccines’ use. Those studies were done before troubling new variants, or versions of the coronavirus, had emerged and started to spread.
A separate report in the medical journal adds to concern about the variants. Scientists measured antibodies that can block the virus in 50 people who had been given the Sinopharm or Sinovac vaccines that were developed in China. Many showed total or partial loss of effectiveness against a virus variant first detected in South Africa.
The vaccines still seemed to protect against a variant first found in the United Kingdom that is now rapidly spreading in the United States and elsewhere.
Pfizer and Moderna have said they are working to update their vaccines, or possibly design a booster shot, in case they’re needed against variants.
US FDA revises Moderna authorization to allow more doses from vialsIn a long-awaited move to increase vaccine supply, the U.S. Food and Drug Administration revised Moderna Inc.’s vaccine authorization to allow the ... Coronavirus
Pfizer, Moderna vaccines reduce COVID-19 infection risk by 90 percent: US studyThe Pfizer and Moderna COVID-19 vaccines were shown to be 90 percent effective against coronavirus infection – regardless of symptom status – in a ... Coronavirus
US scientists doubtful of one-shot regimen for Pfizer, Moderna COVID-19 vaccines: WSJU.S. scientists are skeptical of a one-shot regimen for Pfizer Inc and Moderna Inc COVID-19 vaccines, saying there isn't enough evidence that a single ... Coronavirus
Fauci says US must stick to two-dose strategy for Pfizer, Moderna vaccines: ReportThe United States must stick to a two-dose strategy for the Pfizer-BioNTech and Moderna COVID-19 vaccines, top US infectious disease official Anthony ... Coronavirus